Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
novartis
4
×
cancer
national
national blog main
boston blog main
bristol-myers squibb
cancer immunotherapy
drugs
gene therapy
samit hirawat
#ash2018
2018
abbvie
agios pharmaceuticals
allogene therapeutics
american society of hematology
amgen
aml
ash
bcma
beta-thalassemia
bioinnovation capital
biolabs
biomarin pharmaceutical
bioverativ
bluebird bio
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
car-t
celgene
cell therapy
chemotherapy
chronic lymphocytic leukemia
clinical trials
cll
cooley's anemia foundation
What
medical
4
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
diversity
hirawat
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
trial
year
american
annual
ash
biotech
blood
borne
cancers
conference
diego
driving
drug
gathering
good
guide
healthcare
hematology
history
Language
unset
Current search:
novartis
×
biotech
×
medical
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More